Production and optimization of pterin deaminase from cyanide utilizing bacterium Bacillus cereus AM12

Murugesan Thandeeswaran , Sajitha Bijukumar , Mani Arulkumar , Ramasamy Mahendran , Muthusamy Palaniswamy , Jayaraman Angayarkanni
{"title":"Production and optimization of pterin deaminase from cyanide utilizing bacterium Bacillus cereus AM12","authors":"Murugesan Thandeeswaran ,&nbsp;Sajitha Bijukumar ,&nbsp;Mani Arulkumar ,&nbsp;Ramasamy Mahendran ,&nbsp;Muthusamy Palaniswamy ,&nbsp;Jayaraman Angayarkanni","doi":"10.1016/j.biori.2019.02.003","DOIUrl":null,"url":null,"abstract":"<div><p>In a search of new-fangled antitumor chemotherapeutic agent, the studies are elucidating the enzymes, contributing to the metabolic reprogramming and their potential as therapeutic targets. This study was an endeavor to explore the potential of enzyme pterin deaminase from cyanide degraders. In preliminary and secondary screening, potent cyanide degraders were selected and estimated for pterin deaminase activity. The intracellular crude extract containing enzyme activity was found to be higher in potential strain <em>Bacillus cereus</em> AM12. The optimization conditions for the production of pterin deaminase from this selected strain was studied with the help of Box–Behnken design. The determination coefficient of the model (0.91) was highly significant and indicative of goodness of fit. This design found to be ideal for the selected parameters, such as temperature of 35<!--> <!-->°C, pH 8, 0.005<!--> <!-->M of pterin and 20% of glucose which yielded maximum production of pterin deaminase (9.99<!--> <!-->U/ml). This study might make a major breakthrough in the field of medicine as well as in pharmaceutical compositions when the biological significance of this distinct enzyme is proven.</p></div>","PeriodicalId":100187,"journal":{"name":"Biotechnology Research and Innovation","volume":"3 1","pages":"Pages 159-167"},"PeriodicalIF":0.0000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.biori.2019.02.003","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biotechnology Research and Innovation","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2452072117301144","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 4

Abstract

In a search of new-fangled antitumor chemotherapeutic agent, the studies are elucidating the enzymes, contributing to the metabolic reprogramming and their potential as therapeutic targets. This study was an endeavor to explore the potential of enzyme pterin deaminase from cyanide degraders. In preliminary and secondary screening, potent cyanide degraders were selected and estimated for pterin deaminase activity. The intracellular crude extract containing enzyme activity was found to be higher in potential strain Bacillus cereus AM12. The optimization conditions for the production of pterin deaminase from this selected strain was studied with the help of Box–Behnken design. The determination coefficient of the model (0.91) was highly significant and indicative of goodness of fit. This design found to be ideal for the selected parameters, such as temperature of 35 °C, pH 8, 0.005 M of pterin and 20% of glucose which yielded maximum production of pterin deaminase (9.99 U/ml). This study might make a major breakthrough in the field of medicine as well as in pharmaceutical compositions when the biological significance of this distinct enzyme is proven.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
蜡样芽孢杆菌AM12产蝶呤脱氨酶的研究
在寻找新型抗肿瘤化疗药物的过程中,研究正在阐明代谢重编程的酶及其作为治疗靶点的潜力。本研究旨在探索从氰化物降解物中提取的蝶呤脱氨酶的潜力。在初步和二次筛选中,选择了有效的氰化物降解剂,并对其蝶呤脱氨酶活性进行了评估。蜡样芽孢杆菌AM12的胞内粗提物酶活性较高。利用Box-Behnken设计法对该菌株产蝶呤脱氨酶的最佳条件进行了研究。模型的决定系数(0.91)非常显著,表明拟合优度。当温度为35℃,pH为8,0.005 M的蝶呤和20%的葡萄糖时,该设计是理想的,可以产生最大的蝶呤脱氨酶(9.99 U/ml)。当这种独特的酶的生物学意义得到证实时,这项研究可能会在医学领域以及药物组合物方面取得重大突破。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Antiparasitic activity of lipid extracts from the subantarctic macroalgae Iridea cordata against Trichomonas vaginalis Real-Time PCR Assay for detection and quantification of Leishmania: standardization, positive control, validation, and intra-laboratory assay Survival mechanisms of microorganisms occurring in acid mine drainage: sulfur, iron, carbon, and nitrogen metabolic pathways Biological activities of green coffee nanoemulsions evaluated through alternative methods: MTT, cellular proliferation, and HET-CAM assays Occurrence of fumonisins and strategies for biocontrol in beer production: a systematic review
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1